The CHAF1B subunit is overexpressed in a variety of tumors, including high-grade glioma, melanomas, prostatic, renal, cervical carcinomas, endometrial tumors, hepatocellular, squamous cell carcinoma, salivary gland tumors, leukemia, and breast cancer (19–29) (Table 1). Here, CHAF1B is linked to breast cancer.